Table II.
Molecular Detection of Respiratory Viruses in Pharyngeal Swabs Collected From Hospitalized Children With Acute Respiratory Tract Infections and Children With Viral Respiratory Infections
| Total 240 | 0–6 months 144 (60; 53.7–66.1) | 7–12 months 36 (15; 10.9–19.9) | 13–24 months 45 (18.8; 14.2–24.1) | 25–36 months 15 (6.3; 3.7–9.9) | |
|---|---|---|---|---|---|
| A. Number (95% CI) of infections and age distribution children (N = 240) hospitalized with acute respiratory tract infections | |||||
| Viral agents | |||||
| RSV | 46 (19.2; 14.6–24.5) | 35 (24.3; 17.8–31.8) | 4 (11.1; 3.6–24.7) | 7 (15.5; 7.1–28.4) | 0 |
| hAdV | 28 (11.7; 8.1–16.2) | 13 (9; 5.1–14.6) | 7 (19.4; 8.9–34.7) | 7 (15.5; 7.1–28.4)) | 1 (6.7; 0.3–28.7) |
| hRV | 24 (10; 6.7–14.3) | 14 (9.7; 5.6–15.4) | 5 (13.9; 5.3–28.1) | 4 (8.9; 2.9–20.1) | 1 (6.7; 0.3–28.7) |
| FLU | 11 (4.6; 2.4–7.8) | 5 (3.5; 1.3–7.5) | 2 (5.5; 0.9–17.2) | 4 (8.9; 2.9–20.1) | 0 |
| CoV | 7 (2.9; 1.3–5.7) | 3 (2.1; 0.5–5.6) | 0 | 3 (6.7; 1.7–17.1) | 1 (6.7; 0.3–28.7) |
| hPIV | 1 (0.4; 0.02–2.0) | 0 | 0 | 1 (2.2; 0.1–10.5) | 0 |
| hMPV | 20 (8.3; 5.3–12.4) | 13 (9; 5.1–14.6) | 3 (8.3; 2.2–21) | 4 (8.9; 2.9–20.1) | 0 |
| hBoV | 29 (12; 18.4–16.7) | 14 (9.7; 5.6–15.4) | 4 (11.1; 3.6–24.7) | 11 (24.4;13.6–38.5)a | 0 |
| B. Number (95% CI) of single and co‐infections in patients (N = 131) in the context of age. | |||||
| Total | 131 (54.6; 48.3–60.8) | 76 (52.8; 44.6–60.8)b | 22 (61.1; 44.6–75.9)b | 30 (66.7; 52–79.2)b | 3 (20; 5.4–45.4) |
| Single infections | 102 (77.9; 70.2–84.4) | 58 (76.3; 65.8–84.9) | 19 (86.4; 67.2–96.4) | 22 (73.3; 55.6–86.8) | 3 |
| Co‐infections | 29 (22.1; 15.6–29.9) | 18 (23.7; 15.2–34.2) | 3 (13.6; 3.6–32.8) | 8 (26.7; 13.2–44.4) | 0 |
a
P < 0.05, prevalence of hBoV infections versus that observed in children 0–6 months and 7–12 months of age.
b
P < 0.05, N (%) viral infections versus N (%) of children 25–36 months of age.